Capital Southwest is an internally managed closed-end, non-diversified management investment company. The company's investment objective is to produce risk-adjusted returns by generating current income from its debt investments and capital appreciation from its equity and equity related investments.

Flexos SA.. The Company's principal activity is to undertake activities in the field of computing solutions and security. The Company undertakes selling hardware and software, installation and maintenance of networks, providing different IT services. The Company also provides security to cope with new threats, by providing anti-virus solutions for networks and personal computers, provides firewall facilities for networks and distant access. The Company operates in its domestic market.

Fluidigm creates, manufactures, and markets a range of products and services, including instruments, reagents and software that are used by researchers worldwide. The company markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Prep, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. The company's product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics.

General Finance is a holding company. Through its subsidiaries, the company is a rental services company providing portable storage, modular space and liquid containment solutions. The company's branch locations across North America and the Asia-Pacific provide a range of portable storage units, including its steel containers, office container, mobile office and modular space products and steel tanks that provide the company's customers a way to meet their temporary storage and space needs. The company's customers use its storage and space units for a variety of applications, including the temporary storage of materials, supplies, equipment, retail merchandise inventories, documents and liquid storage and for office use.

Greene County Bancorp is a holding company for its subsidiary, The Bank of Greene County (the Bank). Through the Bank, the company is engaged in accepting retail deposits from the general public in the areas surrounding its branches and investing those deposits, together with funds generated from operations and borrowings, primarily in residential mortgage loans, commercial real estate mortgage loans, consumer loans, home equity loans and commercial business loans. The Bank also invests a portion of its assets in state and political subdivision securities and mortgage-backed securities. The company's other subsidiary, Greene Risk Management, Inc., is operating as a pooled captive insurance company.

Infinity Pharmaceuticals is a biopharmaceutical company focused on developing medicines for people with cancer. The company is focusing its efforts on developing IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate that selectively inhibits the enzyme phosphoinositide-3-kinase-gamma. The company's ongoing Phase 1/1b study MAcrophage Reprogramming in Immuno-Oncology is designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and activity for IPI-549 both as a monotherapy and in combination with nivolumab, also known as Opdivo?, in patients with advanced solid tumors.

Legacy Reserves is engaged in the acquisition and development of oil and natural gas properties. The company owns and operates oil and natural gas producing properties located primarily in East Texas, the Permian Basin (West Texas and Southeast New Mexico), Rocky Mountain and Mid-Continent regions of the United States. The company is focused on two activities: the acquisition of producing oil and natural gas properties and the development of properties in established producing trends. As of Dec 31 2016, the company had proved reserves of 144.8 million barrels of oil equivalent, consisting of 32.5 million barrels of oil, 7.8 million barrels of natural gas liquids, and 627 billion cubic feet of natural gas.

Lexicon Pharmaceuticals is a biopharmaceutical company. The company is commercializing XERMELO? (telotristat ethyl), an orally-delivered small molecule drug for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. The company is developing Zynquista? (sotagliflozin), an orally-delivered small molecule drug candidate, as a treatment for type 1 2 diabetes. The company is also developing sotagliflozin as a treatment for type 2 diabetes, heart failure and chronic kidney disease. The company is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain.

Macquarie Infrastructure is a holding company. The company owns and operates a portfolio of businesses that provide services to other businesses, government agencies and individuals primarily in the U.S. The businesses the company owns and operate are: International-Matex Tank Terminals, which provides bulk liquid terminalling services to third parties in the U.S. and in Canada; Atlantic Aviation, which provides fuel, terminal, aircraft hangaring and other services primarily to owners and operators of general aviation jet aircraft at airports throughout the U.S.; and MIC Hawaii, which consist of energy company that processes and distributes gas and provides related services.